Who should not receive the hemorrhagic fever vaccine?
Generally, individuals who should not receive the hemorrhagic fever vaccine include pregnant or lactating women, those with a history of allergies, individuals with fever, patients with infectious diseases, and patients with neurological disorders. The specific reasons are as follows:
1. Pregnant or lactating women
Pregnant or lactating women should not receive the hemorrhagic fever vaccine, as certain components of the vaccine may affect fetal or infant growth and development.
2. Individuals with a history of allergies
If a patient has a known allergy to any component of the hemorrhagic fever vaccine—including excipients, antibiotics, etc.—or has previously experienced an allergic reaction, vaccination is not recommended, as it may trigger allergic reactions.
3. Individuals with fever
The hemorrhagic fever vaccine is a primary preventive measure against epidemic hemorrhagic fever. After injection, it stimulates the body's immune system to produce corresponding antibodies. During fever, the body's resistance is weakened; administering the vaccine at this time may worsen fever symptoms and potentially reduce vaccine effectiveness.
4. Patients with infectious diseases
If a patient has an infectious disease such as hepatitis, tuberculosis, or HIV/AIDS, receiving the hemorrhagic fever vaccine may lead to further immunosuppression and could induce fever.
5. Patients with neurological disorders
For individuals with neurological conditions such as epilepsy or autonomic nervous system dysfunction, receiving the hemorrhagic fever vaccine during illness may exacerbate their condition and potentially stimulate the nervous system, triggering seizures or episodes of autonomic dysfunction.
If patients experience any discomfort or adverse symptoms, they are advised to seek medical attention promptly to avoid delays in diagnosis and treatment.